Efavirenz
Who holds supplier records for Efavirenz? 11 organisations hold a current record for Efavirenz: an active US FDA Type II Drug Master File. A further 8 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (9) and China (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Efavirenz: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/efavirenz
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
9 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Efavirenz. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 25262, 20015, 24943 +1 · latest filing Sept 2011
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 17802, 19932 · latest filing Oct 2006
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 26242, 21964 · latest filing Jul 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 25190, 29614, 18230 · latest filing Sept 2015
- Arene Life Sciences LimitedIndiaActive DMF 33854 · latest filing Jun 2019
- CDYMAX (INDIA) PHARMA PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 24847 · latest filing Apr 2011
- Cipla LimitedIndia Company GMP cert on recordActive DMF 20711 · latest filing Apr 2008
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 21666 · latest filing May 2008
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaActive DMF 23271 · latest filing Nov 2009
- SMS Pharmaceuticals limitedIndia Company GMP cert on recordActive DMF 34356 · latest filing Mar 2021
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 30959 · latest filing Oct 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (8)
Organisations whose Type II DMFs for Efavirenz are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- ARENE LIFESCIENCES LTDInactive DMF 32188 · filed Nov 2017
- Zhejiang Jiangbei Pharmaceutical Co., Ltd.China · Inactive DMF 31400 · filed Jan 2017
- MYLAN LABORATORIES LTDInactive DMF 21969, 27454 · filed Sept 2013
- India · Inactive DMF 25003 · filed Nov 2011
- India · Inactive DMF 20196, 22704 · filed Apr 2009
- India · Inactive DMF 22708 · filed Apr 2009
- SIBRA PHARMACEUTICALS LTD AN ARCH ENTERPRISEInactive DMF 21708 · filed Jun 2008
- RANBAXY LABORATORIES LTDInactive DMF 20560 · filed May 2007
Overview
Efavirenz is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL223228).
Chemical identity
- IUPAC name
- (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
- Canonical SMILES
- C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
- InChIKey
- XPOQHMRABVBWPR-ZDUSSCGKSA-N
- Synonyms
- DMP-266, (-)-efavirenz, Efavirenz, Efavirenz component of atripla, Efavirenz component of symfi, Efavirenz component of telura, Efavirenz teva, Efavirenzum, L-743726, NSC-742403, Stocrin, Sustiva
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Cytochrome P450 2B6 Inducers; Cytochrome P450 2C19 Inhibitors; Cytochrome P450 2C9 Inhibitors; Cytochrome P450 3A Inducers; Cytochrome P450 3A4 Inhibitors; Non-Nucleoside Reverse Transcriptase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Efavirenz?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Efavirenz: Hetero Labs Limited (India), APITORIA PHARMA PRIVATE LTD (India), Laurus Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Arene Life Sciences Limited (India), CDYMAX (INDIA) PHARMA PRIVATE LIMITED (India), Cipla Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Efavirenz Drug Master Files are active?
Hetero Labs Limited (DMF 25262, 20015), APITORIA PHARMA PRIVATE LTD (DMF 17802, 19932), Laurus Labs Limited (DMF 26242, 21964), MATRIX PHARMACORP PRIVATE LTD (DMF 25190, 29614), Arene Life Sciences Limited (DMF 33854), CDYMAX (INDIA) PHARMA PRIVATE LIMITED (DMF 24847), Cipla Limited (DMF 20711) and Macleods Pharmaceuticals Ltd. (DMF 21666) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Efavirenz records mean?
8 organisations have only inactive Type II DMFs for Efavirenz. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Efavirenz supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Efavirenz?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.